Slight shrinkage occurs early after radical prostatectomy, but by six months, the length returns to what it was before surgery.
Tasquinimod found to improve symptomatic progression, especially among patients with bone metastases.
Template-guided saturation prostate biopsies are no longer necessary when high-quality state-of- the-art mpMRI is available
Predisposing factors include a history of infection and prior abdominal surgery.
Men with a history of prostate cancer are at increased risk of melanoma.
Twelve weeks of Qigong relieved fatigue and distress, researchers report.
The level of expression of three genes associated with aging may be used to predict whether seemly low-risk PCa will remain slow-growing.
A large Swedish study suggests that metabolic factors may increase a man's risk of dying from prostate cancer.
When the pros and cons of PCa treatment are spelled out using an online interactive program, more patients with low-risk PCa choose active surveillance.
Zytiga may significantly delay progression of pain and quality of life deterioration in patients with mCRPC.
The guideline recommends that patients with adverse pathologic findings at prostatectomy should be offered adjuvant radiotherapy.
Investigators say they may have found a new way to more accurately predict prostate cancer patients' prognoses.
Compared with placebo, enzalutamide reduced the risk of death by 30% and the risk of radiographic progression or death by 81%.
Only 9.5% of the study participants were told about the possibilities of overdiagnosis and overtreatment by their physicians.
Texas study shows that PSA screening was ordered for 41% of men aged 75 and older, largely because of decisions by primary-care physicians.
The study, sponsored by a group representing radiation oncologists, concluded that urologists use IMRT more if their practices offer it.
Potential psychological harm associated with biopsy even in absence of cancer diagnosis.
Most want to be told of screening harms, but only 9.5 percent informed about overdiagnosis, overtx.
Study also shows that different statins vary in their protective effect.
3-month urinary, sexual function scores predict 12-month outcomes in prostate cancer survivors.
It does not improve disease-specific or overall survival in intermediate-risk PCa patients compared with short-term suppression.
New studies have confirmed biological differences in prostate tumors between African American men and European American men.
The University of Michigan Health System is offering a new urine test called Mi-Prostate Score to improve on PSA screening.
Biopsy-related procedures accounted for much of the cost.
Data suggest that sipuleucel-T is effective despite comcomitant abiraterone treatment and cabazitaxel may have advantages over abiraterone for second-line therapy.
MRI may enable doctors to predict the likelihood of biochemical recurrence of PCa after radical prostatectomy.
The 10-year rates of cancer-specific and overall survival were 95.2% and 79.8%.
Inflammation in prostate biopsy specimens is not a useful indicator in PCa screening, researchers conclude.
Worse outcomes linked to abnormal breaks at certain chromosomal sites sensitive to DNA damage.
The risk of ED is increased by about 75% if hypertension, diabetes, and hyperlipidemia are present concomitantly.